PTCT
PTC Therapeutics, Inc.$60.33+0.44 (+0.73%)Prev Close$59.97·MCap$5.01B·P/E8.58·Vol355.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
65
$49.92M
◆
Net Activity
Net Seller
$49.92M
●
Active Insiders
13
last 12 mo
Over the past 12 months, insider activity at PTC Therapeutics, Inc. (PTCT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 65 insider sales totaling $49.92M. The most recent insider transaction was by SCHMERTZLER MICHAEL (director), who sold $149.0K worth of shares on Oct 16, 2026. PTC Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $5.01B.
PTCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $59.61 | $149.0K | 1,291,976 |
| Oct 13, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 192 | $64.26 | $12.3K | 105,272 |
| Oct 9, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $63.39 | $158.5K | 1,294,147 |
| Oct 7, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,073 | $64.06 | $132.8K | 105,272 |
| Oct 2, 2026 | STEELE GLENN JR MD PHD | director | Sell | 12,000 | $65.16 | $781.9K | 22,500-35% |
| Sep 18, 2026 | SCHMERTZLER MICHAEL | director | Sell | 20,000 | $67.49 | $1.35M | 1,313,600 |
| Sep 11, 2026 | SCHMERTZLER MICHAEL | director | Sell | 20,000 | $67.59 | $1.35M | 1,327,166 |
| Aug 28, 2026 | SCHMERTZLER MICHAEL | director | Sell | 25,000 | $72.26 | $1.81M | 1,354,720 |
| Aug 21, 2026 | SCHMERTZLER MICHAEL | director | Sell | 25,000 | $72.22 | $1.81M | 1,381,259 |
| Aug 19, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,813 | $72.57 | $204.1K | 106,241 |
| Aug 6, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,292 | $68.57 | $705.7K | 383,868 |
| Jul 16, 2026 | Gravier Pierre | officer: CHIEF FINANCIAL OFFICER | Sell | 3,494 | $80.35 | $280.7K | 83,986 |
| Jul 13, 2026 | Smith Mary L. | director | Sell | 5,834 | $90.00 | $525.1K | 21,813 |
| Jul 13, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 2,464 | $90.25 | $222.4K | 60,299 |
| Jul 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 4,478 | $84.90 | $380.2K | 107,698 |
| Jul 8, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 46,774 | $87.52 | $4.09M | 80,956-37% |
| Jun 30, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 8,130 | $85.26 | $693.2K | 60,137 |
| Jun 26, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 26,283 | $85.78 | $2.25M | 71,474-27% |
| Jun 24, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 23,749 | $80.90 | $1.92M | 71,756 |
| Jun 22, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 10,462 | $78.65 | $822.9K | 107,122 |
| Jun 22, 2026 | Utter Christine Marie | officer: SVP, CHIEF ACCOUNTING OFFICER | Sell | 19,686 | $75.56 | $1.49M | 70,199 |
| May 19, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,812 | $72.18 | $203.0K | 105,668 |
| May 15, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 12,572 | $72.95 | $917.2K | 405,891 |
| May 12, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 3,540 | $78.97 | $279.6K | 107,112 |
| Apr 23, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,850 | $70.91 | $202.1K | 394,070 |
| Apr 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,265 | $69.45 | $157.3K | 106,655 |
| Apr 6, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 829 | $67.99 | $56.4K | 79,115 |
| Mar 13, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,662 | $64.08 | $170.6K | 396,920 |
| Mar 12, 2026 | Okey Stephanie | director | Sell | 14,000 | $70.00 | $980.0K | 8,000-64% |
| Mar 9, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 3,989 | $63.38 | $252.8K | 2,737-59% |
| Mar 9, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 10,000 | $63.38 | $633.8K | 79,944 |
| Mar 9, 2026 | Okey Stephanie | director | Sell | 6,333 | $63.38 | $401.4K | 8,000-44% |
| Feb 19, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 3,019 | $69.48 | $209.8K | 0 |
| Feb 18, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 3,121 | $69.36 | $216.5K | 0 |
| Feb 18, 2026 | Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 2,484 | $69.36 | $172.3K | 0 |
| Feb 18, 2026 | Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 2,992 | $69.36 | $207.5K | 0 |
| Feb 18, 2026 | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 7,371 | $69.36 | $511.3K | 0 |
| Feb 18, 2026 | Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 3,019 | $69.36 | $209.4K | 0 |
| Feb 18, 2026 | Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 2,494 | $69.36 | $173.0K | 0 |
| Feb 17, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 5,894 | $69.33 | $408.6K | 0 |
| Jan 12, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 940 | $76.45 | $71.9K | 115,196 |
| Jan 12, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 6,347 | $77.06 | $489.1K | 115,177 |
| Jan 12, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 866 | $76.45 | $66.2K | 92,428 |
| Jan 12, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,514 | $76.45 | $192.2K | 394,453 |
| Jan 12, 2026 | Pauwels Eric | officer: CHIEF BUSINESS OFFICER | Sell | 7,348 | $77.02 | $565.9K | 84,928 |
| Jan 12, 2026 | Utter Christine Marie | officer: SVP, CHIEF ACCOUNTING OFFICER | Sell | 1,034 | $76.45 | $79.0K | 72,693 |
| Jan 8, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 2,411 | $77.19 | $186.1K | 117,103 |
| Jan 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 6,618 | $77.31 | $511.6K | 119,162 |
| Jan 8, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 1,982 | $77.12 | $152.9K | 93,936 |
| Jan 8, 2026 | Gravier Pierre | officer: CHIEF FINANCIAL OFFICER | Sell | 2,139 | $76.95 | $164.6K | 90,310 |
Showing 1–50 of 208
1 / 5
PTCT Insider Buying Activity
The following table shows recent insider purchases of PTC Therapeutics, Inc. (PTCT) stock reported via SEC Form 4 filings.
No insider buying activity found for PTCT in the last 12 months.
PTCT Insider Selling Activity
The following table shows recent insider sales of PTC Therapeutics, Inc. (PTCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $59.61 | $149.0K | 1,291,976 |
| Oct 13, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 192 | $64.26 | $12.3K | 105,272 |
| Oct 9, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,500 | $63.39 | $158.5K | 1,294,147 |
| Oct 7, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,073 | $64.06 | $132.8K | 105,272 |
| Oct 2, 2026 | STEELE GLENN JR MD PHD | director | Sell | 12,000 | $65.16 | $781.9K | 22,500-35% |
| Sep 18, 2026 | SCHMERTZLER MICHAEL | director | Sell | 20,000 | $67.49 | $1.35M | 1,313,600 |
| Sep 11, 2026 | SCHMERTZLER MICHAEL | director | Sell | 20,000 | $67.59 | $1.35M | 1,327,166 |
| Aug 28, 2026 | SCHMERTZLER MICHAEL | director | Sell | 25,000 | $72.26 | $1.81M | 1,354,720 |
| Aug 21, 2026 | SCHMERTZLER MICHAEL | director | Sell | 25,000 | $72.22 | $1.81M | 1,381,259 |
| Aug 19, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,813 | $72.57 | $204.1K | 106,241 |
| Aug 6, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,292 | $68.57 | $705.7K | 383,868 |
| Jul 16, 2026 | Gravier Pierre | officer: CHIEF FINANCIAL OFFICER | Sell | 3,494 | $80.35 | $280.7K | 83,986 |
| Jul 13, 2026 | Smith Mary L. | director | Sell | 5,834 | $90.00 | $525.1K | 21,813 |
| Jul 13, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 2,464 | $90.25 | $222.4K | 60,299 |
| Jul 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 4,478 | $84.90 | $380.2K | 107,698 |
| Jul 8, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 46,774 | $87.52 | $4.09M | 80,956-37% |
| Jun 30, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 8,130 | $85.26 | $693.2K | 60,137 |
| Jun 26, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 26,283 | $85.78 | $2.25M | 71,474-27% |
| Jun 24, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 23,749 | $80.90 | $1.92M | 71,756 |
| Jun 22, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 10,462 | $78.65 | $822.9K | 107,122 |
| Jun 22, 2026 | Utter Christine Marie | officer: SVP, CHIEF ACCOUNTING OFFICER | Sell | 19,686 | $75.56 | $1.49M | 70,199 |
| May 19, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,812 | $72.18 | $203.0K | 105,668 |
| May 15, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 12,572 | $72.95 | $917.2K | 405,891 |
| May 12, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 3,540 | $78.97 | $279.6K | 107,112 |
| Apr 23, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,850 | $70.91 | $202.1K | 394,070 |
| Apr 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 2,265 | $69.45 | $157.3K | 106,655 |
| Apr 6, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 829 | $67.99 | $56.4K | 79,115 |
| Mar 13, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,662 | $64.08 | $170.6K | 396,920 |
| Mar 12, 2026 | Okey Stephanie | director | Sell | 14,000 | $70.00 | $980.0K | 8,000-64% |
| Mar 9, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 3,989 | $63.38 | $252.8K | 2,737-59% |
| Mar 9, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 10,000 | $63.38 | $633.8K | 79,944 |
| Mar 9, 2026 | Okey Stephanie | director | Sell | 6,333 | $63.38 | $401.4K | 8,000-44% |
| Feb 19, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 3,019 | $69.48 | $209.8K | 0 |
| Feb 18, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 3,121 | $69.36 | $216.5K | 0 |
| Feb 18, 2026 | Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 2,484 | $69.36 | $172.3K | 0 |
| Feb 18, 2026 | Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 2,992 | $69.36 | $207.5K | 0 |
| Feb 18, 2026 | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 7,371 | $69.36 | $511.3K | 0 |
| Feb 18, 2026 | Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 3,019 | $69.36 | $209.4K | 0 |
| Feb 18, 2026 | Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 2,494 | $69.36 | $173.0K | 0 |
| Feb 17, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 5,894 | $69.33 | $408.6K | 0 |
| Jan 12, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 940 | $76.45 | $71.9K | 115,196 |
| Jan 12, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 6,347 | $77.06 | $489.1K | 115,177 |
| Jan 12, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 866 | $76.45 | $66.2K | 92,428 |
| Jan 12, 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 2,514 | $76.45 | $192.2K | 394,453 |
| Jan 12, 2026 | Pauwels Eric | officer: CHIEF BUSINESS OFFICER | Sell | 7,348 | $77.02 | $565.9K | 84,928 |
| Jan 12, 2026 | Utter Christine Marie | officer: SVP, CHIEF ACCOUNTING OFFICER | Sell | 1,034 | $76.45 | $79.0K | 72,693 |
| Jan 8, 2026 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | Sell | 2,411 | $77.19 | $186.1K | 117,103 |
| Jan 8, 2026 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | Sell | 6,618 | $77.31 | $511.6K | 119,162 |
| Jan 8, 2026 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | Sell | 1,982 | $77.12 | $152.9K | 93,936 |
| Jan 8, 2026 | Gravier Pierre | officer: CHIEF FINANCIAL OFFICER | Sell | 2,139 | $76.95 | $164.6K | 90,310 |
PTCT Insiders
Similar Stocks to PTCT
MRNA
Moderna, Inc.
$224.46+1.31%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$968.49+4.34%
$83.15B
RVMD
Revolution Medicines, Inc.
$189.93-0.72%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$160.93-2.49%
$30.46B
UTHR
United Therapeutics Corporation
$594.37-0.66%
$25.15B
INCY
Incyte Corporation
$118.78-1.19%
$23.69B
INSM
Insmed Incorporated
$110.67-1.70%
$21.18B
EXEL
Exelixis, Inc.
$71.28+2.82%
$16.64B